GUMDROP : JHMI R0926 Phase II, Stage T1 Bladder Cancer, Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Cisplatin Chemotherapy Following a Thorough Transurethral Surgical Re-Staging

Created by Channing Paller, last modified on Apr 14, 2012

Description:

Path- or cyto-confirmed stage T1 w/ histopathologic grade 2 or 3 TCC of the bladder; candidate for radical cystectomy; no mets; no systemic chemo

Link:

http://clinicaltrials.gov/ct2/show/NCT00981656

Site:

Johns Hopkins Hospital

Principal Investigator:

Danny Song, M.D.